{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anogeissus leiocarpus", "Cell death", "Cell proliferation", "Free radicals", "HepG2 cells", "Morphological changes", "Resveratrol"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28768515", "DateCompleted": {"Year": "2017", "Month": "09", "Day": "01"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "08", "Day": "02"}], "Language": ["eng"], "ELocationID": ["381", "10.1186/s12906-017-1873-2"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "17", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Aug", "Day": "02"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "A comparative assessment of antiproliferative properties of resveratrol and ethanol leaf extract of Anogeissus leiocarpus (DC) Guill and Perr against HepG2 hepatocarcinoma cells.", "Pagination": {"StartPage": "381", "MedlinePgn": "381"}, "Abstract": {"AbstractText": ["Epidemiological and experimental evidences have shown cancer as a leading cause of death worldwide. Although the folklore use of plants as a reliable source of health-restoring principles is well-documented, the search for more of such plants that are active against diseases, such as cancer, continues. We report here a laboratory-based evidence of the relevance of an ethanol leaf extract of Anogeissus leiocarpus (A2L) in comparison with resveratrol, a natural polyphenol, in cancer therapy.", "The quantitative assessment of flavonoid and phenolic contents involved quercetin and gallic acid as standards, respectively were determined using spectrophotometry. Cytotoxicity was determined fluorometrically using propidium-iodide-staining method. Antioxidant status, adenosine triphosphate (ATP) levels, caspase activities and mitochondrial integrity were assessed using fluorometry/luminometry.", "The antioxidant assay demonstrated that A2L possesses a strong antioxidant capacity as compared with the reference compounds, ascorbic acid and butylated hydroxytoluene. This is further buttressed by the significantly high level of phenolics obtained in the quantitative assessment of the extract. A 72-h post-treatment examination indicated that both A2L and resveratrol modulate the proliferation of HepG2 liver carcinoma cells in a time- and concentration-dependent manner. Determination of the total nuclei area, propidium-iodide negative and positive nuclei areas all further buttress the modulation of cell proliferation by A2L and resveratrol with the indication that the observed cell death is due to apoptosis and necrosis at lower and higher concentrations of treatments respectively. At lower concentrations (0.39-3.13\u00a0\u03bcg/mL), resveratrol possesses higher tendencies to activate caspases 3 and 7. Bioenergetically, both resveratrol and A2L do not adversely affect the cells at lower concentrations (0.39-6.25\u00a0\u03bcg/mL for resveratrol and 12.5-100.0\u00a0\u03bcg/mL for A2L) except at higher concentrations (12.5-25.0\u00a0\u03bcg/mL for resveratrol and 200-800\u00a0\u03bcg/mL for A2L) which are more pronounced in A2L-treated cells. Furthermore, the antioxidant status of HepG2 cells is not perturbed by resveratrol as compared with A2L. Assessment of 24-h post-treatment mitochondrial function shows that resveratrol is not mitotoxic as compared with A2L which exhibits mitotoxicity at its highest concentration.", "Taken together, findings from this study showed that A2L possesses strong antiproliferative activity and its prospect in the management of hepatocellular carcinoma deserves further investigation."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Cancer Research and Molecular Biology (CRMB) Laboratories, University of Ibadan, Ibadan, Oyo, Nigeria."}, {"Identifier": [], "Affiliation": "Department of Chemistry and Biochemistry, University of California, Los Angeles, California, USA."}, {"Identifier": [], "Affiliation": "Nano and Pico Characterisation (NPC) Core Facility, California NanoSystems Institute (CNSI), University of California, Los Angeles, California, USA."}], "LastName": "Olugbami", "ForeName": "Jeremiah Olorunjuwon", "Initials": "JO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Screening and Shared Resources (MSSR) Core Facility, California NanoSystems Institute (CNSI), University of California, Los Angeles, California, USA."}, {"Identifier": [], "Affiliation": "Department of Molecular and Medicinal Pharmacology, University of California, Los Angeles, California, USA."}], "LastName": "Damoiseaux", "ForeName": "Robert", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Screening and Shared Resources (MSSR) Core Facility, California NanoSystems Institute (CNSI), University of California, Los Angeles, California, USA."}], "LastName": "France", "ForeName": "Bryan", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Sciences, Ajayi Crowther University, Oyo, Oyo, Nigeria."}], "LastName": "Onibiyo", "ForeName": "Esther Modupe", "Initials": "EM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Cancer Research and Molecular Biology (CRMB) Laboratories, University of Ibadan, Ibadan, Oyo, Nigeria."}], "LastName": "Gbadegesin", "ForeName": "Michael Adedapo", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nano and Pico Characterisation (NPC) Core Facility, California NanoSystems Institute (CNSI), University of California, Los Angeles, California, USA."}], "LastName": "Sharma", "ForeName": "Shivani", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry and Biochemistry, University of California, Los Angeles, California, USA."}, {"Identifier": [], "Affiliation": "Nano and Pico Characterisation (NPC) Core Facility, California NanoSystems Institute (CNSI), University of California, Los Angeles, California, USA."}, {"Identifier": [], "Affiliation": "International Center for Materials Nanoarchitectonics Satellite (MANA), National Institute for Materials Science (NIMS), Tsukuba, Japan."}], "LastName": "Gimzewski", "ForeName": "James Kazimierz", "Initials": "JK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Cancer Research and Molecular Biology (CRMB) Laboratories, University of Ibadan, Ibadan, Oyo, Nigeria. ronodunola@yahoo.com."}], "LastName": "Odunola", "ForeName": "Oyeronke Adunni", "Initials": "OA"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenols"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Stilbenes"}, {"RegistryNumber": "8L70Q75FXE", "NameOfSubstance": "Adenosine Triphosphate"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspases"}, {"RegistryNumber": "Q369O8926L", "NameOfSubstance": "Resveratrol"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Adenosine Triphosphate"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspases"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["chemistry", "classification"], "DescriptorName": "Combretaceae"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Mitochondria"}, {"QualifierName": [], "DescriptorName": "Necrosis"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Phenols"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plant Leaves"}, {"QualifierName": [], "DescriptorName": "Resveratrol"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Stilbenes"}], "CoiStatement": "ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Intensive trainings by UCLA office of Environment, Health and Safety (EHS) and immunisation were undertaken before access was granted to carry out this study. No human subject was used. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER\u2019S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman DD, bray F. cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u2013E386. doi: 10.1002/ijc.29210.", "ArticleIdList": ["10.1002/ijc.29210", "25220842"]}, {"Citation": "Kalimuthu S, Se-Kwon K. Cell survival and apoptosis signaling as therapeutic target for cancer: marine bioactive compounds. Int J Mol Sci. 2013;14:2334\u20132354. doi: 10.3390/ijms14022334.", "ArticleIdList": ["10.3390/ijms14022334", "PMC3587990", "23348928"]}, {"Citation": "Farombi EO, Adepoju BF, Ola-Davies OE, Emerole GO. Chemoprevention of aflatoxin B1-induced genotoxicity and hepatic oxidative damage in rats by kolaviron, a natural bioflavonoid of Garcinia kola seeds. Eur J Cancer Prev. 2005;14:207\u2013214. doi: 10.1097/00008469-200506000-00003.", "ArticleIdList": ["10.1097/00008469-200506000-00003", "15901988"]}, {"Citation": "Mann A, Amupitan JO, Oyewale AO, Okogun JI, Ibrahim K. An ethnobotanical survey of indigenous flora for treating tuberculosis and other respiratory diseases in Niger state, Nigeria. J Phytomedicine Ther. 2007;12:1\u201321."}, {"Citation": "Agaie BM, Onyeyili PA, Muhammad BY, Ladan MJ. Acute toxicity effects of the aqueous leaf extract of Anogeissus leiocarpus in rats. African J Biotechnol. 2007;6(7):886\u2013889."}, {"Citation": "Takaoka MJ. Of the phenolic substances of white hellebore (Veratrum grandiflorum Loes. Fil.) J Fac Sci Hokkaido Imp Univ. 1940;3:1\u201316."}, {"Citation": "Hsieh TC, Wu JM. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res. 1999;249(1):109\u2013115. doi: 10.1006/excr.1999.4471.", "ArticleIdList": ["10.1006/excr.1999.4471", "10328958"]}, {"Citation": "Ou X, Chen Y, Cheng X, Zhang X, He Q. Potentiation of resveratrol-induced apoptosis by matrine in human hepatoma HepG2 cells. Oncol Rep. 2014;32(6):2803\u20132809.", "ArticleIdList": ["25269486"]}, {"Citation": "Olugbami JO, Gbadegesin MA, Odunola OA. In vitro evaluation of the antioxidant potential, phenolic and flavonoid contents of the stem bark ethanol extract of Anogeissus leiocarpus. Afr J Med Med Sci. 2014;43(Suppl 1):101\u20139.", "ArticleIdList": ["PMC4679201", "26681826"]}, {"Citation": "Spanos GA, Wrolstad RE. Influence of processing and storage on the phenolic composition of Thompson seedless grape juice. J Agric Food Chem. 1990;38(7):1565\u20131571. doi: 10.1021/jf00097a030.", "ArticleIdList": ["10.1021/jf00097a030"]}, {"Citation": "Olugbami JO, Gbadegesin MA, Odunola OA. In vitro free radical scavenging and antioxidant properties of ethanol extract of Terminalia glaucescens. Pharm Res. 2015;7(1):49\u201356.", "ArticleIdList": ["PMC4285649", "25598635"]}, {"Citation": "Nickavar B, Kamalinejad M, Mohandesi S. Comparison of the components of the essential oils from leaves and fruits of Grammosciadium platycarpum. Chem Nat Compd. 2006;42:686\u2013688. doi: 10.1007/s10600-006-0252-x.", "ArticleIdList": ["10.1007/s10600-006-0252-x"]}, {"Citation": "Elkholi IE, Hazem NM, ElKashef WF, Sobh MA, Shaalan D, Sobh M, El-Sherbiny IM. Evaluation of anti-cancer potential of capsaicin-loaded trimethyl chitosan-based nanoparticles in HepG2 hepatocarcinoma cells. J Nanomedicine Nanotechnol. 2014;5(6):1\u20138. doi: 10.4172/2157-7439.1000240.", "ArticleIdList": ["10.4172/2157-7439.1000240"]}, {"Citation": "Li L, Wei XH, Pan YP, Li HC, Yang H, He QH, Pang Y, Shan Y, Xiong FX, Shao GZ, Zhou RL. LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling. Oncogene. 2010;29(43):5785\u20135795. doi: 10.1038/onc.2010.303.", "ArticleIdList": ["10.1038/onc.2010.303", "20711237"]}, {"Citation": "Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2(9):533\u2013543. doi: 10.1016/S1470-2045(01)00486-7.", "ArticleIdList": ["10.1016/S1470-2045(01)00486-7", "11905707"]}, {"Citation": "Ortega AL, Mena S, Estrela JM. Glutathione in cancer cell death. Cancers (Basel) 2011;3(1):1285\u20131310. doi: 10.3390/cancers3011285.", "ArticleIdList": ["10.3390/cancers3011285", "PMC3756414", "24212662"]}, {"Citation": "Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res. 1996;25(1):57\u201374. doi: 10.3109/10715769609145656.", "ArticleIdList": ["10.3109/10715769609145656", "8814444"]}, {"Citation": "Lim YY, Lim TT, Tee JJ. Antioxidant properties of several tropical fruits: a comparative study. Food Chem. 2007;103(3):1003\u20131008. doi: 10.1016/j.foodchem.2006.08.038.", "ArticleIdList": ["10.1016/j.foodchem.2006.08.038"]}, {"Citation": "Dorman HJD, Ko\u015far M, Kahlos K, Holm Y, Hiltunen R. Antioxidant properties and composition of aqueous extracts from Mentha species, hybrids, varieties, and cultivars. J Agric Food Chem. 2003;51(16):4563\u20134569. doi: 10.1021/jf034108k.", "ArticleIdList": ["10.1021/jf034108k", "14705878"]}, {"Citation": "Notas G, Nifli A-P, Kampa M, Vercauteren J, Kouroumalis E, Castanas E. Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochim Biophys Acta. 2006;1760(11):1657\u20131666. doi: 10.1016/j.bbagen.2006.09.010.", "ArticleIdList": ["10.1016/j.bbagen.2006.09.010", "17052855"]}, {"Citation": "Yu H, Li D, Zhang H, Xue H, Pan C, Zhao S, Wang L. Resveratrol inhibits invasion and metastasis of hepatocellular carcinoma cells. J Anim Vet Adv. 2010;9(24):3117\u201324. doi: 10.3923/javaa.2010.3117.3124.", "ArticleIdList": ["10.3923/javaa.2010.3117.3124"]}, {"Citation": "Stervbo U, Vang O, Bonnesen C. Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Prolif. 2006;39(6):479\u2013493. doi: 10.1111/j.1365-2184.2006.00406.x.", "ArticleIdList": ["10.1111/j.1365-2184.2006.00406.x", "PMC6496894", "17109633"]}, {"Citation": "Zhu Y, Huang H, Wu Y. Anticancer and apoptotic activities of oleanolic acid are mediated through cell cycle arrest and disruption of mitochondrial membrane potential in HepG2 human hepatocellular carcinoma cells. Mol Med Rep. 2015;12(4):5012\u20135018.", "ArticleIdList": ["PMC4581805", "26151733"]}, {"Citation": "Olugbami JO, Damoiseaux R, France B, Gbadegesin MA, Stieg AZ, Sharma S, Odunola OA, Gimzewski JK. Atomic force microscopy correlates antimetastatic potentials of HepG2 cell line with its redox/energy status, and effects of curcumin and Khaya senegalensis. J Integr Med. 2017;15(3):214\u2013230.", "ArticleIdList": ["PMC6497468", "28494852"]}, {"Citation": "Gallis JL, Serhan N, Gin H, Couzigou P, Beauvieux MC. Resveratrol plus ethanol counteract the ethanol-induced impairment of energy metabolism: 31P NMR study of ATP and sn-glycerol-3-phosphate on isolated and perfused rat liver. Pharm Res. 2012;65(3):387\u2013395. doi: 10.1016/j.phrs.2011.12.003.", "ArticleIdList": ["10.1016/j.phrs.2011.12.003", "22227530"]}, {"Citation": "Kim S-K, Joe Y, Zheng M, Kim HJ, Yu J-K, Cho GJ, Chang KC, Kim HK, Han J, Ryter SW, Chung HT. Resveratrol induces hepatic mitochondrial biogenesis through the sequential activation of nitric oxide and carbon monoxide production. Antioxid Redox Signal. 2014;20(16):2589\u20132605. doi: 10.1089/ars.2012.5138.", "ArticleIdList": ["10.1089/ars.2012.5138", "PMC4024846", "24041027"]}, {"Citation": "Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337\u2013342. doi: 10.1038/nature05354.", "ArticleIdList": ["10.1038/nature05354", "PMC4990206", "17086191"]}, {"Citation": "Nah H, Lee W, Joo Y, Kim H, Choi S, Rew J, Kim SJ, Jung YD, Ahn BW, Park JS. Resveratrol protects HepG2 and chang liver cells from oxidative stress. Chonnam Med J. 2005;41:243\u2013252."}, {"Citation": "Faghihzadeh F, Hekmatdoost A, Adibi P. Resveratrol and liver: a systematic review. J Res Med Sci. 2015;20(8):797\u2013810. doi: 10.4103/1735-1995.168405.", "ArticleIdList": ["10.4103/1735-1995.168405", "PMC4652315", "26664429"]}, {"Citation": "Kai L, Samuel SK, Levenson AS. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. Int J Cancer. 2010;126(7):1538\u20131548.", "ArticleIdList": ["19810103"]}]}], "History": [{"Year": "2017", "Month": "2", "Day": "13"}, {"Year": "2017", "Month": "7", "Day": "7"}, {"Year": "2017", "Month": "8", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["28768515", "PMC5541659", "10.1186/s12906-017-1873-2", "10.1186/s12906-017-1873-2"]}}]}